Siglec-9(+) tumor-associated macrophages delineate an immunosuppressive subset with therapeutic vulnerability in patients with high-grade serous ovarian cancer

BACKGROUND: The potent immunosuppressive properties of sialic acid-binding immunoglobulin-like lectin-9 (Siglec-9) on myeloid cells and lymphocytes provide a strong rationale for serving as a therapeutic target. However, the expression profile and critical role of Siglec-9 in high-grade serous ovari...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yiying, He, Mengdi, Zhang, Chen, Cao, Kankan, Zhang, Guodong, Yang, Moran, Huang, Yan, Jiang, Wei, Liu, Haiou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503378/
https://www.ncbi.nlm.nih.gov/pubmed/37709296
http://dx.doi.org/10.1136/jitc-2023-007099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503378/
https://www.ncbi.nlm.nih.gov/pubmed/37709296
http://dx.doi.org/10.1136/jitc-2023-007099

Ejemplares similares